Biomarkers that can detect PD pathology and that can detect disease progression will be most helpful for patient care and proper clinical trial design. As part of the NINDS Parkinson's Disease Biomarkers Program, we seek to collect biological specimens from PD patients and identify serum biomarkers for disease identification and tracking disease progression.

Public Health Relevance

Because the prevalence of Parkinson's disease (PD) is on the rise, it is a public health necessity that the disease be diagnosed at its earliest stage in a relatively non-invasive manner. Biomarkers that can detect PD pathology, and that can detect disease progression would be most helpful for patient care and for proper clinical trial design. The current project seeks to identify serum biomarkers for PD and collect clinical data and new biological specimens from PD patients as part of the NINDS Parkinson's Disease Biomarkers Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01NS082148-01
Application #
8473525
Study Section
Special Emphasis Panel (ZNS1-SRB-J (02))
Program Officer
Sieber, Beth-Anne
Project Start
2012-09-30
Project End
2017-08-31
Budget Start
2012-09-30
Budget End
2013-08-31
Support Year
1
Fiscal Year
2012
Total Cost
$645,302
Indirect Cost
$239,452
Name
University of Texas Sw Medical Center Dallas
Department
Psychiatry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Gwinn, Katrina; David, Karen K; Swanson-Fischer, Christine et al. (2017) Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomark Med 11:451-473
Yazdani, Umar; Zaman, Sayed; Hynan, Linda S et al. (2016) Blood biomarker for Parkinson disease: peptoids. NPJ Parkinsons Dis 2:
Rosenthal, Liana S; Drake, Daniel; Alcalay, Roy N et al. (2016) The NINDS Parkinson's disease biomarkers program. Mov Disord 31:915-23
Samudra, Niyatee; Patel, Neepa; Womack, Kyle B et al. (2016) Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management. Drugs Aging 33:855-863
Nalls, Mike A; McLean, Cory Y; Rick, Jacqueline et al. (2015) Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol 14:1002-9
Dewey, D Campbell; Miocinovic, Svjetlana; Bernstein, Ira et al. (2014) Automated gait and balance parameters diagnose and correlate with severity in Parkinson disease. J Neurol Sci 345:131-8